Discovery - Top 10

Journal/Proceeding/Conference

(3)

Language

Search

Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 1-25 of 154 (Search time: 0.01 seconds).

TitleAuthor(s)Issue Date
 
2011
 
2020
 
2019
 
2020
 
Identification of a novel RHO GTPase activating protein called DLC2, involved in hepatocellular carcinoma
Proceeding/Conference:International Symposium of the Society of Chinese Bioscientistis in America, SCBA 2004
2004
 
Genetic and epigenetic alterations on DLC-1 gene in hepatocellular carcinoma
Proceeding/Conference:Proceedings of the American Association for Cancer Research
2003
 
2004
 
2004
 
Study of cellular behaviour on micro- and nano- structures
Proceeding/Conference:IET Hong Kong Younger Members Exhibition/Conference, YMEC2009
2009
 
Characterization of candidate tumor suppressor gene, DLC-1 in hepatocellular carcinoma
Proceeding/Conference:World Congress of Digestive Surgery & HKICC 2002
2002
 
Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity
Journal:Proceedings of the National Academy of Sciences of the United States of America
2005
 
2005
 
Functional characterization of the liver-enriched transcription factor CREB-H
Proceeding/Conference:Annual Meeting of the American Society for Cell Biology, ASCB 2005
2005
 
2008
 
Rho-kinase 2 (ROCK2) is involved in hepatocellular carcinoma progression, metastasis and invasion
Proceeding/Conference:Annual Meeting of the International Liver Cancer Association, ILCA 2008
2008
 
Tumor suppressor deleted in liver cancer-1 (DLC-1) gene triggers apoptosis in NPC cells by perturbing mitochondria (MI)
Proceeding/Conference:Biennial Conference of the International Association for Research on EBV & Associated Diseases
2008
 
2009
 
Frequent upregulation of enhancer of zeste homolog 2 was implicated in deleted in liver cancer 1 gene silencing and HCC progression
Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2010
2010
 
MiR-139 suppresses metastasis and progression of hepatocellular carcinoma through regulation of Rho-Kinase 2 (ROCK2)
Proceeding/Conference:Annual Conference of the International Liver Cancer Association, ILCA 2010
2010
2010
 
Epigenetic dysregulation of microRNA-9 in hepatocellular carcinoma (HCC)
Proceeding/Conference:Meeting of the European Association for Cancer Research, EACR-21
2010
 
2013
 
2013
 
2013
 
2013